📚 Pharmacol Res

Articles (6)

• The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good.

  👤 Gray, Paul E 👤 Belessis, Yvonne ⏰ 2020 📚 Pharmacol Res

• Corrigendum to "Traditional Chinese medicine for COVID-19 treatment" [Pharmacol. Res. 155 (2020) 104743].

  👤 Ren, Jun-Ling 👤 Zhang, Ai-Hua 👤 Wang, Xi-Jun ⏰ 2020 📚 Pharmacol Res

• Traditional Chinese medicine for COVID-19 treatment.

  👤 Ren, Jun-Ling 👤 Zhang, Ai-Hua 👤 Wang, Xi-Jun ⏰ 2020 📚 Pharmacol Res

• Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).

  👤 Runfeng, Li 👤 Yunlong, Hou 👤 Jicheng, Huang 👤 Weiqi, Pan 👤 Qinhai, Ma 👤 Yongxia, Shi 👤 Chufang, Li 👤 Jin, Zhao 👤 Zhenhua, Jia 👤 Haiming, Jiang 👤 Kui, Zheng 👤 Shuxiang, Huang 👤 Jun, Dai 👤 Xiaobo, Li 👤 Xiaotao, Hou 👤 Lin, Wang 👤 Nanshan, Zhong 👤 Zifeng, Yang ⏰ 2020 📚 Pharmacol Res

• 3CL(pro) inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.

  👤 Sisay, Mekonnen ⏰ 2020 📚 Pharmacol Res

• Reply to "The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good".

  👤 Zhang, Ai-Hua 👤 Ren, Jun-Ling 👤 Wang, Xi-Jun ⏰ 2020 📚 Pharmacol Res